Fagron N.V. — Capital/Financing Update 2013

Sep 30, 2013

Waregem (Belgium) / Rotterdam (the Netherlands)¹ , 30 September 2013 – Arseus announces today that three companies have acceded as "Guarantor" in accordance with the Guarantee Declaration dated 12 June 2012 regarding the € 225,000,000 4.75% Bond with maturity date 2 July 2017:

• B&B Pharmaceuticals, Inc.
• Fagron, Inc.
• Freedom Pharmaceuticals, Inc.

The list of Guarantors has been updated in accordance with Article 10.4 of the Guarantee Declaration and is available at www.arseus.com.

In accordance with Condition 10 (b) of the Bonds a new Compliance Certificate is published. This Compliance Certificate is available at www.arseus.com.

In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.

For more information: Constantijn van Rietschoten Director of Corporate Communications +31 88 33 11 222 (Office) +31 6 53 69 15 85 (Mobile) constantijn.van.rietschoten@arseus.com

¹ This press release was sent out by Arseus NV and Arseus BV.

Arseus profile

Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.